blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3595682

EP3595682 - COMPOSITIONS AND METHODS FOR SELECTIVE ELIMINATION AND REPLACEMENT OF HEMATOPOIETIC STEM CELLS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  11.12.2020
Database last updated on 05.10.2024
FormerRequest for examination was made
Status updated on  20.12.2019
FormerThe international publication has been made
Status updated on  22.09.2018
Formerunknown
Status updated on  17.04.2018
Most recent event   Tooltip21.08.2024New entry: Reply to examination report 
Applicant(s)For all designated states
Poseida Therapeutics, Inc.
4242 Campus Point Court
Suite 700
San Diego, CA 92121 / US
[2020/04]
Inventor(s)01 / OSTERTAG, Eric
9390 Town Centre Drive, Suite 200
San Diego, California 92121 / US
02 / SHEDLOCK, Devon
9390 Town Centre Drive, Suite 200
San Diego, California 92121 / US
03 / DOWN, Julian David
9390 Town Centre Drive, Suite 200
San Diego, California 92121 / US
 [2020/08]
Former [2020/04]01 / OSTERTAG, Eric
4242 Campus Point Court
Suite 700
San Diego, California 92121 / US
02 / SHEDLOCK, Devon
4242 Campus Point Court
Suite 700
San Diego, California 92121 / US
03 / DOWN, Julian David
4242 Campus Pont Drive
San Diego, California 92121 / US
Representative(s)Cooley (UK) LLP
22 Bishopsgate
London EC2N 4BQ / GB
[N/P]
Former [2020/04]Cooley (UK) LLP
Dashwood
69 Old Broad Street
London EC2M 1QS / GB
Application number, filing date18715336.613.03.2018
[2020/04]
WO2018US22169
Priority number, dateUS201762470814P13.03.2017         Original published format: US 201762470814 P
US201762596062P07.12.2017         Original published format: US 201762596062 P
[2020/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018169948
Date:20.09.2018
Language:EN
[2018/38]
Type: A1 Application with search report 
No.:EP3595682
Date:22.01.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 20.09.2018 takes the place of the publication of the European patent application.
[2020/04]
Search report(s)International search report - published on:EP20.09.2018
ClassificationIPC:A61K35/17, A61K35/28, A61K48/00, C12N5/0783, C12N15/09
[2020/04]
CPC:
C12N5/0636 (EP,IL,KR,US); A61K31/7076 (IL,KR,US); A61K39/4631 (EP,IL,KR,US);
A61K39/001111 (CN); A61K31/664 (IL,US); A61K31/675 (IL,KR);
A61K35/17 (IL); A61K35/28 (EP,IL,KR,US); A61K38/177 (IL,US);
A61K38/1774 (IL,US); A61K38/193 (IL,US); A61K38/4873 (EP,IL,KR,US);
A61K38/52 (IL,US); A61K39/39 (IL,US); A61K39/3955 (IL,US);
A61K39/4611 (EP,IL,KR,US); A61K39/464402 (EP,IL,KR,US); A61K39/464411 (EP,IL,KR);
A61K45/06 (CN,IL,KR,US); A61K9/0019 (IL,US); A61K9/0085 (IL,US);
A61P29/00 (EP,IL,KR); A61P35/00 (EP,IL,KR); A61P35/02 (CN);
A61P37/00 (EP,IL,KR); A61P37/02 (EP,IL); C07K14/7051 (CN);
C07K16/2803 (CN); C12N15/11 (IL,US); C12N9/1241 (IL,US);
C12N9/22 (IL,US); C12Y207/07 (IL,US); C12Y304/22055 (EP,IL,KR);
C12Y304/22062 (IL,US); C12Y502/01008 (IL,US); A61K2039/5156 (CN);
A61K2300/00 (IL,KR); C07K2317/622 (CN); C07K2319/02 (CN);
C07K2319/03 (CN); C07K2319/33 (CN); C07K2319/74 (CN);
C12N2310/20 (IL,US); C12N2510/00 (EP,IL,KR,US); C12N2800/80 (IL,US);
C12N2800/90 (EP,IL,KR) (-)
C-Set:
A61K35/28, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/04]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUM SELEKTIVEN ELIMINIEREN UND ERSETZEN VON HÄMATOPOIETISCHEN STAMMZELLEN[2020/04]
English:COMPOSITIONS AND METHODS FOR SELECTIVE ELIMINATION AND REPLACEMENT OF HEMATOPOIETIC STEM CELLS[2020/04]
French:COMPOSITIONS ET PROCÉDÉS D'ÉLIMINATION ET DE REMPLACEMENT SÉLECTIFS DE CELLULES SOUCHES HÉMATOPOÏÉTIQUES[2020/04]
Entry into regional phase11.10.2019National basic fee paid 
11.10.2019Designation fee(s) paid 
11.10.2019Examination fee paid 
Examination procedure11.10.2019Examination requested  [2020/04]
11.10.2019Date on which the examining division has become responsible
20.04.2020Amendment by applicant (claims and/or description)
14.12.2020Despatch of a communication from the examining division (Time limit: M06)
22.06.2021Reply to a communication from the examining division
26.04.2022Despatch of a communication from the examining division (Time limit: M06)
02.11.2022Reply to a communication from the examining division
17.04.2024Despatch of a communication from the examining division (Time limit: M04)
19.08.2024Reply to a communication from the examining division
Fees paidRenewal fee
27.03.2020Renewal fee patent year 03
29.03.2021Renewal fee patent year 04
28.03.2022Renewal fee patent year 05
27.03.2023Renewal fee patent year 06
27.03.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inby applicantUS5733746
 US4656134
 US4683195
 US4683202
 US4704692
 US4766067
 US4795699
 US4800159
 US4889818
 US4921794
 US4939666
 US4946778
 US4965188
 US4994370
 WO9117271
 US5066584
 WO9118980
 WO9119818
 US5091310
 WO9205258
 US5122464
 US5130238
 US5142033
 WO9214843
 WO9216221
 US5168062
 WO9308278
 US5223409
 US5260203
 US5266491
 US5385839
 US5403484
 US5427908
 US5455030
 US5518889
 WO9619256
 US5534621
 US5571698
 US5576195
 US5580717
 US5580734
 US5595898
 US5618920
 US5641670
 US5643768
 US5656730
 US5658754
 US5693493
 US5698435
 US5698417
 US5733761
 US5750373
 US5763733
 US5767260
 US5770359
 US5827739
 US5837500
 US5856456
 US5885793
 WO2016US37922
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.